AQUESTIVE THERAPEUTICS INC's ticker is AQST and the CUSIP is 03843E104. A total of 49 filers reported holding AQUESTIVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 2.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,725 | -7.3% | 14,853 | 0.0% | 0.00% | – |
| Q2 2023 | $24,507 | +44.7% | 14,853 | 0.0% | 0.00% | – |
| Q1 2023 | $16,932 | +26.4% | 14,853 | 0.0% | 0.00% | – |
| Q4 2022 | $13,399 | -21.2% | 14,853 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | +70.0% | 14,853 | 0.0% | 0.00% | – |
| Q2 2022 | $10,000 | -96.7% | 14,853 | -87.0% | 0.00% | – |
| Q1 2022 | $299,000 | -33.0% | 114,623 | 0.0% | 0.00% | – |
| Q4 2021 | $446,000 | -11.2% | 114,623 | -0.4% | 0.00% | – |
| Q3 2021 | $502,000 | +9.4% | 115,043 | -0.6% | 0.00% | – |
| Q2 2021 | $459,000 | -46.3% | 115,723 | -29.5% | 0.00% | – |
| Q1 2021 | $854,000 | +77.2% | 164,259 | +82.5% | 0.00% | – |
| Q4 2020 | $482,000 | +95.1% | 90,019 | +76.8% | 0.00% | – |
| Q3 2020 | $247,000 | -14.2% | 50,926 | -14.1% | 0.00% | – |
| Q2 2020 | $288,000 | +54.8% | 59,268 | +120.7% | 0.00% | – |
| Q1 2019 | $186,000 | +72.2% | 26,849 | +56.8% | 0.00% | – |
| Q4 2018 | $108,000 | – | 17,124 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bratton Capital Management, L.P. | 11,503,294 | $55,848,000 | 77.67% |
| Bracebridge Capital, LLC | 428,571 | $2,083,000 | 0.33% |
| Oak Grove Capital LLC | 89,000 | $432,000 | 0.20% |
| Perceptive Advisors | 1,750,000 | $8,496,000 | 0.12% |
| Virtu Financial LLC | 117,206 | $569,000 | 0.10% |
| WEDBUSH SECURITIES INC | 103,240 | $501,000 | 0.05% |
| J. Goldman & Co LP | 117,600 | $571,000 | 0.04% |
| Engineers Gate Manager LP | 68,300 | $332,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 118,900 | $577,000 | 0.01% |
| Brandywine Global Investment Management, LLC | 137,029 | $666,000 | 0.01% |